Logo 1 Logo 2

Clinical Trial Details

Trial ID: L7002
Source ID: NCT00678145
Associated Drug: Naloxone
Title: Mechanisms of Hypoglycemia Associated Autonomic Failure
Acronym:
Status: UNKNOWN
Study Results: NO
Results:
Conditions: Diabetes Mellitus|Hypoglycemia|Autonomic Failure
Interventions: DRUG: naloxone|DIETARY_SUPPLEMENT: fructose|BEHAVIORAL: exercise|DRUG: Morphine sulfate|DRUG: Epinephrine
Outcome Measures: Primary: Change in the counterregulatory responses to hypoglycemia compared to controls, Measurements of counterregulatory hormones will be measured throughout the study, Measured every 15 minutes at timepoints 0, 15, 30, 45...120 through study completion | Secondary: Symptom scores, Symptoms of hypoglycemia will be taken during the study, Measured every 15 minutes at timepoints 0, 15, 30, 45...120 through study completion
Sponsor/Collaborators: Sponsor: Albert Einstein College of Medicine | Collaborators: National Institutes of Health (NIH)|National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Gender: ALL
Age: ADULT
Phases: PHASE2
Enrollment: 116
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: BASIC_SCIENCE
Start Date: 2008-03
Completion Date: 2022-08
Results First Posted:
Last Update Posted: 2021-01-14
Locations: Albert Einstein College of Medicine / General Clinical Research Center, Bronx, New York, 10461, United States
URL: https://clinicaltrials.gov/show/NCT00678145